Swedish Orphan Biovitrum AB (publ) (BIT:1SOBI)
36.62
+1.66 (4.75%)
At close: Feb 11, 2026
BIT:1SOBI Revenue
In the year 2025, Swedish Orphan Biovitrum AB had annual revenue of 28.24B SEK with 8.50% growth. Swedish Orphan Biovitrum AB had revenue of 7.82B in the quarter ending December 31, 2025, with 5.19% growth.
Revenue
28.24B SEK
Revenue Growth
+8.50%
P/S Ratio
5.00
Revenue / Employee
14.96M SEK
Employees
1,888
Market Cap
13.06B EUR
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.24B | 2.21B | 8.50% |
| Dec 31, 2024 | 26.03B | 3.90B | 17.65% |
| Dec 31, 2023 | 22.12B | 3.33B | 17.74% |
| Dec 31, 2022 | 18.79B | 3.26B | 21.00% |
| Dec 31, 2021 | 15.53B | 268.00M | 1.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Stellantis | 146.12B |
| Edison | 15.39B |
| Telecom Italia | 14.43B |
| Unipol Assicurazioni | 10.54B |
| Mediobanca Banca di Credito Finanziario | 3.32B |
| Moncler | 3.10B |
| Italgas | 3.05B |
| Recordati Industria Chimica e Farmaceutica | 2.55B |